EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The development of orally active peptides: Prioritizing drug-likeness or bioactivity?

Sanhu Gou, Zufang Ba, Bingqian Ren, Hui Liu, Yun Zhang, Chao Zhong, Yongxi Dong, Jingman Ni

Acta Pharmaceutica Sinica B · 2026-10

DOI: 10.1016/j.apsb.2026.10.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-10. Verfasst von Sanhu Gou und 7 weiteren Autor:innen. Die Arbeit nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • CAMS Innovation Fund for Medical Sciences
  • National Natural Science Foundation of China

Zitieren

APA

Gou, S., Ba, Z., Ren, B., Liu, H., Zhang, Y., Zhong, C., Dong, Y., & Ni, J. (2026). The development of orally active peptides: Prioritizing drug-likeness or bioactivity?. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.10.032

Vancouver

Gou S, Ba Z, Ren B, Liu H, Zhang Y, Zhong C, et al. The development of orally active peptides: Prioritizing drug-likeness or bioactivity?. Acta Pharmaceutica Sinica B. 2026. doi:10.1016/j.apsb.2026.10.032

BibTeX
@article{Gou2026,
  author = {Gou, Sanhu and Ba, Zufang and Ren, Bingqian and Liu, Hui and Zhang, Yun and Zhong, Chao and Dong, Yongxi and Ni, Jingman},
  title = {The development of orally active peptides: Prioritizing drug-likeness or bioactivity?},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  doi = {10.1016/j.apsb.2026.10.032}
}
Kostenlos starten →